Jumin Huang

1.6k total citations · 2 hit papers
25 papers, 832 citations indexed

About

Jumin Huang is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Jumin Huang has authored 25 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Immunology. Recurrent topics in Jumin Huang's work include Cancer Immunotherapy and Biomarkers (7 papers), Ginseng Biological Effects and Applications (5 papers) and Immune Cell Function and Interaction (4 papers). Jumin Huang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Ginseng Biological Effects and Applications (5 papers) and Immune Cell Function and Interaction (4 papers). Jumin Huang collaborates with scholars based in Macao, China and United States. Jumin Huang's co-authors include Elaine Lai‐Han Leung, Zebo Jiang, Xing‐Xing Fan, Qibiao Wu, Chun Xie, Ya‐Jia Xie, Wenjun Wang, Peiyu Yan, Xiaojun Yao and Xuan‐Run Wang and has published in prestigious journals such as Nature Communications, Immunological Reviews and Antioxidants and Redox Signaling.

In The Last Decade

Jumin Huang

25 papers receiving 828 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer

2021 177 citations Zebo Jiang, Wenjun Wang et al. Cancer Letters profile →
Selective utilization of medicinal polysaccharides by human gut Bacteroides and Parabacteroides species

2025 25 citations Zepeng Qu, Hongbin Liu et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jumin Huang Macao	15	419	207	136	127	124	25	832
Jimin Zhao China	17	509 1.2×	213 1.0×	112 0.8×	99 0.8×	156 1.3×	70	897
Lehe Yang China	18	396 0.9×	275 1.3×	72 0.5×	111 0.9×	134 1.1×	42	878
Ming Yue Li China	17	480 1.1×	194 0.9×	127 0.9×	59 0.5×	189 1.5×	30	884
Anna L. Greenshields Canada	16	550 1.3×	159 0.8×	94 0.7×	142 1.1×	162 1.3×	41	1.2k
Nipin Sp South Korea	19	587 1.4×	202 1.0×	133 1.0×	89 0.7×	186 1.5×	41	1.2k
Mohammad Tarique India	18	454 1.1×	295 1.4×	200 1.5×	59 0.5×	74 0.6×	46	1.1k
Feifeng Song China	15	320 0.8×	187 0.9×	107 0.8×	67 0.5×	93 0.8×	53	717
Thazin Nwe Aung United States	16	531 1.3×	265 1.3×	247 1.8×	91 0.7×	161 1.3×	50	994
Lingtao Jin United States	10	452 1.1×	123 0.6×	144 1.1×	67 0.5×	192 1.5×	14	869
Anqi Zeng China	17	435 1.0×	131 0.6×	85 0.6×	54 0.4×	136 1.1×	45	858

Countries citing papers authored by Jumin Huang

Since Specialization

Citations

This map shows the geographic impact of Jumin Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jumin Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jumin Huang more than expected).

Fields of papers citing papers by Jumin Huang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jumin Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jumin Huang. The network helps show where Jumin Huang may publish in the future.

Co-authorship network of co-authors of Jumin Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Jumin Huang. A scholar is included among the top collaborators of Jumin Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jumin Huang. Jumin Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Qu, Zepeng, Hongbin Liu, Jumin Huang, et al.. (2025). Selective utilization of medicinal polysaccharides by human gut Bacteroides and Parabacteroides species. Nature Communications. 16(1). 638–638. 25 indexed citations breakdown →

Han, Yan, Jumin Huang, Yuwei Wang, et al.. (2025). Berbamine as potential STING inhibitor For KRAS-mutant non-small cell lung cancer. Pharmacological Research. 216. 107777–107777. 2 indexed citations

Xu, Jiahui, Ziming Wang, Yuping Tang, et al.. (2024). TRP channels in cancer: Therapeutic opportunities and research strategies. Pharmacological Research. 209. 107412–107412. 4 indexed citations

Zhang, Yizhong, Huanling Lai, Chen Huang, et al.. (2024). Tanshinone IIA induces ER stress and JNK activation to inhibit tumor growth and enhance anti-PD-1 immunotherapy in non-small cell lung cancer. Phytomedicine. 128. 155431–155431. 12 indexed citations

Huang, Jumin, Xuan‐Run Wang, Ziming Wang, et al.. (2023). Extracellular vesicles as a novel mediator of interkingdom communication. Cytokine & Growth Factor Reviews. 73. 173–184. 36 indexed citations

Huang, Jumin, Weitong Zhang, Yifan Wang, et al.. (2023). Harnessing natural product polysaccharides against lung cancer and revisit its novel mechanism. Pharmacological Research. 199. 107034–107034. 14 indexed citations

Zhang, Jing, Jiaxin He, Jumin Huang, et al.. (2023). Pharmacokinetics, absorption and transport mechanism for ginseng polysaccharides. Biomedicine & Pharmacotherapy. 162. 114610–114610. 19 indexed citations

Wang, Jian, Wenjun Wang, Lee‐Fong Yau, et al.. (2023). CERS4 predicts positive anti-PD-1 response and promotes immunomodulation through Rhob-mediated suppression of CD8+Tim3+ exhausted T cells in non-small cell lung cancer. Pharmacological Research. 194. 106850–106850. 13 indexed citations

Leung, Elaine Lai‐Han, Runze Li, Xing‐Xing Fan, et al.. (2023). Longitudinal high-dimensional analysis identifies immune features associating with response to anti-PD-1 immunotherapy. Nature Communications. 14(1). 5115–5115. 14 indexed citations

10.

Leung, Elaine Lai‐Han, Jumin Huang, Junmin Zhang, et al.. (2022). Novel Anticancer Strategy by Targeting the Gut Microbial Neurotransmitter Signaling to Overcome Immunotherapy Resistance. Antioxidants and Redox Signaling. 38(4-6). 298–315. 3 indexed citations

11.

Leung, Elaine Lai‐Han, Xing‐Xing Fan, Jumin Huang, et al.. (2022). Holistic immunomodulation for small cell lung cancer. Seminars in Cancer Biology. 88. 96–105. 6 indexed citations

12.

Huang, Min, Dan Li, Ya‐Jia Xie, et al.. (2022). PA-MSHA induces inflamed tumor microenvironment and sensitizes tumor to anti-PD-1 therapy. Cell Death and Disease. 13(11). 931–931. 6 indexed citations

13.

Fan, Xiaoqing, Chu-Tian Mai, Ling Zuo, et al.. (2022). Herbal formula BaWeiBaiDuSan alleviates polymicrobial sepsis-induced liver injury via increasing the gut microbiota Lactobacillus johnsonii and regulating macrophage anti-inflammatory activity in mice. Acta Pharmaceutica Sinica B. 13(3). 1164–1179. 46 indexed citations

14.

Jiang, Zebo, Wenjun Wang, Cong Xu, et al.. (2021). Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer. Cancer Letters. 515. 36–48. 177 indexed citations breakdown →

15.

Li, Jiaxin, Runze Li, Ao Sun, et al.. (2021). Metabolomics and integrated network pharmacology analysis reveal Tricin as the active anti-cancer component of Weijing decoction by suppression of PRKCA and sphingolipid signaling. Pharmacological Research. 171. 105574–105574. 67 indexed citations

16.

Jiang, Zebo, Cong Xu, Wenjun Wang, et al.. (2021). Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8+ T cells. Pharmacological Research. 169. 105656–105656. 33 indexed citations

17.

Huang, Jumin, Zebo Jiang, Yuwei Wang, et al.. (2020). Modulation of gut microbiota to overcome resistance to immune checkpoint blockade in cancer immunotherapy. Current Opinion in Pharmacology. 54. 1–10. 45 indexed citations

18.

Jiang, Zebo, Jumin Huang, Ya‐Jia Xie, et al.. (2020). Evodiamine suppresses non-small cell lung cancer by elevating CD8+ T cells and downregulating the MUC1-C/PD-L1 axis. Journal of Experimental & Clinical Cancer Research. 39(1). 249–249. 93 indexed citations

19.

Wang, Wenjun, Huanling Lai, Yuwei Wang, et al.. (2020). Dolutegravir derivative inhibits proliferation and induces apoptosis of non-small cell lung cancer cells via calcium signaling pathway. Pharmacological Research. 161. 105129–105129. 30 indexed citations

20.

Wang, Qianqian, Jiahui Xu, Ying Li, et al.. (2018). Identification of a Novel Protein Arginine Methyltransferase 5 Inhibitor in Non-small Cell Lung Cancer by Structure-Based Virtual Screening. Frontiers in Pharmacology. 9. 173–173. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact